Memorial Sloan Kettering Medical Oncologist Alexander Drilon

Areas of Expertise

Conditions I Treat

  • Lung cancer

My Specialties

  • Early-phase clinical trials
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a medical oncologist who specializes in the treatment of lung cancer. I work with a team of experts including surgeons, radiation oncologists, pathologists, and nurses. Our goal is to provide the best possible care and support for patients and their families.

As a member of the Thoracic Oncology Service, my research is focused on developing new treatments for lung cancer. I have a particular interest in studying ways to target molecular changes in patients’ tumors with new medicines.

I also specialize in early-phase clinical trials and am a member of our Developmental Therapeutics group. Our aim is to bring new drugs to patients with all types of cancer, particularly those for whom standard treatments have been exhausted.

I speak English, Spanish, and Filipino.

What I Do at MSK

I'm a thoracic medical oncologist, which is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.

I'm an early drug development specialist, which is a scientist who tests new drugs to treat cancer. I have special training in research studies, also known as clinical trials.

  • Chief, Early Drug Development Service
Areas of Expertise

Conditions I Treat

  • Lung cancer

My Specialties

  • Early-phase clinical trials
Education & Honors

Education

  • MD, University of the Philippines

Residencies

  • Internal Medicine - St. Luke's-Roosevelt Hospital Center

Fellowships

  • Medical Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

  • Internal Medicine
  • Medical Oncology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Early Drug Development Service doctors

See all Thoracic Oncology Service doctors

Clinical Trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Drilon’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Alexander Drilon discloses the following relationships and financial interests:

  • Academy for Continued Healthcare Learning
    Professional Services and Activities
  • AnHeart Therapeutics Inc.
    Professional Services and Activities
  • Associazione Italiana Oncologia Toracica (AIOT)
    Professional Services and Activities
  • Bayer
    Professional Services and Activities
  • Boundless Bio, Inc.
    Professional Services and Activities
  • Bristol-Myers Squibb
    Professional Services and Activities
  • BroadcastMed
    Professional Services and Activities
  • EcoR1 Capital LLC
    Professional Services and Activities
  • IDEOlogy Health, LLC
    Professional Services and Activities
  • Loxo Oncology
    Professional Services and Activities
  • LUNGevity Foundation, Inc.
    Professional Services and Activities
  • MBrace Therapeutics, Inc.
    Equity
  • Medscape
    Professional Services and Activities
  • MJH Life Sciences
    Professional Services and Activities
  • Northwell Health
    Professional Services and Activities
  • Nuvalent, Inc.
    Professional Services and Activities
  • OncLive
    Professional Services and Activities
  • Physicians' Education Resource
    Professional Services and Activities
  • Springer Nature Limited
    Professional Services and Activities
  • Total CME
    Professional Services and Activities
  • Treeline Biosciences, Inc.
    Equity; Professional Services and Activities
  • Zymeworks Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures